Intrinsic value of DaVita - DVA

Previous Close

$69.98

  Intrinsic Value

$77.48

stock screener

  Rating & Target

hold

+11%

Previous close

$69.98

 
Intrinsic value

$77.48

 
Up/down potential

+11%

 
Rating

hold

We calculate the intrinsic value of DVA stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 2017), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 13.2

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
   2018
   2019
   2020
   2021
   2022
   2023
   2024
   2025
   2026
   2027
   2028
   2029
   2030
   2031
   2032
   2033
   2034
   2035
   2036
   2037
   2038
   2039
   2040
   2041
   2042
   2043
   2044
   2045
   2046
   2047

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  2.00
  2.30
  2.57
  2.81
  3.03
  3.23
  3.41
  3.57
  3.71
  3.84
  3.95
  4.06
  4.15
  4.24
  4.31
  4.38
  4.44
  4.50
  4.55
  4.59
  4.64
  4.67
  4.70
  4.73
  4.76
  4.78
  4.81
  4.83
  4.84
  4.86
Revenue, $m
  11,095
  11,350
  11,641
  11,969
  12,332
  12,730
  13,163
  13,633
  14,138
  14,681
  15,261
  15,881
  16,540
  17,241
  17,985
  18,773
  19,607
  20,490
  21,422
  22,406
  23,445
  24,540
  25,694
  26,911
  28,192
  29,541
  30,961
  32,455
  34,026
  35,680
Variable operating expenses, $m
  8,995
  9,187
  9,406
  9,651
  9,923
  10,222
  10,547
  10,899
  11,279
  11,686
  11,449
  11,913
  12,408
  12,934
  13,492
  14,083
  14,709
  15,371
  16,070
  16,809
  17,588
  18,409
  19,275
  20,188
  21,149
  22,161
  23,226
  24,347
  25,526
  26,766
Fixed operating expenses, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total operating expenses, $m
  8,995
  9,187
  9,406
  9,651
  9,923
  10,222
  10,547
  10,899
  11,279
  11,686
  11,449
  11,913
  12,408
  12,934
  13,492
  14,083
  14,709
  15,371
  16,070
  16,809
  17,588
  18,409
  19,275
  20,188
  21,149
  22,161
  23,226
  24,347
  25,526
  26,766
Operating income, $m
  2,099
  2,163
  2,236
  2,318
  2,408
  2,508
  2,616
  2,733
  2,860
  2,995
  3,813
  3,967
  4,132
  4,307
  4,493
  4,690
  4,898
  5,119
  5,352
  5,597
  5,857
  6,131
  6,419
  6,723
  7,043
  7,380
  7,735
  8,108
  8,500
  8,913
EBITDA, $m
  3,731
  3,817
  3,915
  4,025
  4,147
  4,281
  4,427
  4,585
  4,755
  4,937
  5,133
  5,341
  5,563
  5,799
  6,049
  6,314
  6,594
  6,891
  7,205
  7,536
  7,885
  8,253
  8,641
  9,051
  9,481
  9,935
  10,413
  10,915
  11,444
  12,000
Interest expense (income), $m
  407
  504
  519
  537
  558
  581
  607
  635
  665
  699
  734
  773
  814
  858
  904
  954
  1,007
  1,062
  1,121
  1,184
  1,250
  1,319
  1,393
  1,470
  1,552
  1,638
  1,729
  1,824
  1,925
  2,030
  2,141
Earnings before tax, $m
  1,595
  1,644
  1,699
  1,760
  1,827
  1,901
  1,981
  2,068
  2,161
  2,261
  3,040
  3,153
  3,274
  3,403
  3,539
  3,683
  3,836
  3,997
  4,168
  4,348
  4,538
  4,738
  4,949
  5,171
  5,405
  5,651
  5,910
  6,183
  6,470
  6,772
Tax expense, $m
  431
  444
  459
  475
  493
  513
  535
  558
  583
  610
  821
  851
  884
  919
  956
  994
  1,036
  1,079
  1,125
  1,174
  1,225
  1,279
  1,336
  1,396
  1,459
  1,526
  1,596
  1,669
  1,747
  1,828
Net income, $m
  1,164
  1,200
  1,240
  1,285
  1,334
  1,388
  1,446
  1,510
  1,577
  1,650
  2,219
  2,302
  2,390
  2,484
  2,583
  2,689
  2,800
  2,918
  3,042
  3,174
  3,312
  3,459
  3,612
  3,775
  3,946
  4,125
  4,315
  4,514
  4,723
  4,944

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  19,328
  19,773
  20,281
  20,852
  21,484
  22,177
  22,933
  23,750
  24,631
  25,576
  26,588
  27,667
  28,816
  30,037
  31,332
  32,706
  34,159
  35,696
  37,320
  39,035
  40,844
  42,752
  44,764
  46,883
  49,115
  51,465
  53,938
  56,541
  59,279
  62,160
Adjusted assets (=assets-cash), $m
  19,328
  19,773
  20,281
  20,852
  21,484
  22,177
  22,933
  23,750
  24,631
  25,576
  26,588
  27,667
  28,816
  30,037
  31,332
  32,706
  34,159
  35,696
  37,320
  39,035
  40,844
  42,752
  44,764
  46,883
  49,115
  51,465
  53,938
  56,541
  59,279
  62,160
Revenue / Adjusted assets
  0.574
  0.574
  0.574
  0.574
  0.574
  0.574
  0.574
  0.574
  0.574
  0.574
  0.574
  0.574
  0.574
  0.574
  0.574
  0.574
  0.574
  0.574
  0.574
  0.574
  0.574
  0.574
  0.574
  0.574
  0.574
  0.574
  0.574
  0.574
  0.574
  0.574
Average production assets, $m
  9,597
  9,818
  10,070
  10,353
  10,667
  11,011
  11,386
  11,792
  12,230
  12,699
  13,201
  13,737
  14,307
  14,914
  15,557
  16,239
  16,960
  17,723
  18,530
  19,381
  20,280
  21,227
  22,226
  23,278
  24,386
  25,553
  26,781
  28,073
  29,433
  30,863
Working capital, $m
  -333
  -340
  -349
  -359
  -370
  -382
  -395
  -409
  -424
  -440
  -458
  -476
  -496
  -517
  -540
  -563
  -588
  -615
  -643
  -672
  -703
  -736
  -771
  -807
  -846
  -886
  -929
  -974
  -1,021
  -1,070
Total debt, $m
  9,613
  9,947
  10,329
  10,759
  11,234
  11,755
  12,323
  12,938
  13,601
  14,312
  15,072
  15,883
  16,747
  17,666
  18,640
  19,673
  20,766
  21,921
  23,143
  24,432
  25,793
  27,228
  28,740
  30,334
  32,012
  33,780
  35,640
  37,597
  39,656
  41,822
Total liabilities, $m
  14,535
  14,869
  15,251
  15,680
  16,156
  16,677
  17,245
  17,860
  18,523
  19,233
  19,994
  20,805
  21,669
  22,588
  23,562
  24,595
  25,688
  26,843
  28,065
  29,354
  30,715
  32,150
  33,662
  35,256
  36,934
  38,702
  40,562
  42,519
  44,578
  46,744
Total equity, $m
  4,793
  4,904
  5,030
  5,171
  5,328
  5,500
  5,687
  5,890
  6,109
  6,343
  6,594
  6,861
  7,146
  7,449
  7,770
  8,111
  8,471
  8,853
  9,255
  9,681
  10,129
  10,603
  11,101
  11,627
  12,180
  12,763
  13,377
  14,022
  14,701
  15,416
Total liabilities and equity, $m
  19,328
  19,773
  20,281
  20,851
  21,484
  22,177
  22,932
  23,750
  24,632
  25,576
  26,588
  27,666
  28,815
  30,037
  31,332
  32,706
  34,159
  35,696
  37,320
  39,035
  40,844
  42,753
  44,763
  46,883
  49,114
  51,465
  53,939
  56,541
  59,279
  62,160
Debt-to-equity ratio
  2.010
  2.030
  2.050
  2.080
  2.110
  2.140
  2.170
  2.200
  2.230
  2.260
  2.290
  2.310
  2.340
  2.370
  2.400
  2.430
  2.450
  2.480
  2.500
  2.520
  2.550
  2.570
  2.590
  2.610
  2.630
  2.650
  2.660
  2.680
  2.700
  2.710
Adjusted equity ratio
  0.248
  0.248
  0.248
  0.248
  0.248
  0.248
  0.248
  0.248
  0.248
  0.248
  0.248
  0.248
  0.248
  0.248
  0.248
  0.248
  0.248
  0.248
  0.248
  0.248
  0.248
  0.248
  0.248
  0.248
  0.248
  0.248
  0.248
  0.248
  0.248
  0.248

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  1,164
  1,200
  1,240
  1,285
  1,334
  1,388
  1,446
  1,510
  1,577
  1,650
  2,219
  2,302
  2,390
  2,484
  2,583
  2,689
  2,800
  2,918
  3,042
  3,174
  3,312
  3,459
  3,612
  3,775
  3,946
  4,125
  4,315
  4,514
  4,723
  4,944
Depreciation, amort., depletion, $m
  1,632
  1,654
  1,679
  1,708
  1,739
  1,774
  1,811
  1,852
  1,895
  1,942
  1,320
  1,374
  1,431
  1,491
  1,556
  1,624
  1,696
  1,772
  1,853
  1,938
  2,028
  2,123
  2,223
  2,328
  2,439
  2,555
  2,678
  2,807
  2,943
  3,086
Funds from operations, $m
  2,796
  2,854
  2,919
  2,992
  3,073
  3,161
  3,257
  3,361
  3,473
  3,593
  3,539
  3,676
  3,821
  3,975
  4,139
  4,313
  4,496
  4,690
  4,895
  5,112
  5,340
  5,581
  5,835
  6,102
  6,384
  6,681
  6,993
  7,321
  7,667
  8,030
Change in working capital, $m
  -7
  -8
  -9
  -10
  -11
  -12
  -13
  -14
  -15
  -16
  -17
  -19
  -20
  -21
  -22
  -24
  -25
  -26
  -28
  -30
  -31
  -33
  -35
  -36
  -38
  -40
  -43
  -45
  -47
  -50
Cash from operations, $m
  2,803
  2,862
  2,928
  3,002
  3,084
  3,173
  3,270
  3,375
  3,488
  3,609
  3,557
  3,694
  3,841
  3,996
  4,161
  4,336
  4,521
  4,717
  4,923
  5,141
  5,372
  5,614
  5,870
  6,139
  6,423
  6,721
  7,035
  7,366
  7,714
  8,079
Maintenance CAPEX, $m
  -941
  -960
  -982
  -1,007
  -1,035
  -1,067
  -1,101
  -1,139
  -1,179
  -1,223
  -1,270
  -1,320
  -1,374
  -1,431
  -1,491
  -1,556
  -1,624
  -1,696
  -1,772
  -1,853
  -1,938
  -2,028
  -2,123
  -2,223
  -2,328
  -2,439
  -2,555
  -2,678
  -2,807
  -2,943
New CAPEX, $m
  -184
  -221
  -252
  -283
  -314
  -344
  -375
  -406
  -437
  -469
  -502
  -536
  -570
  -606
  -643
  -682
  -722
  -763
  -806
  -851
  -898
  -947
  -999
  -1,052
  -1,108
  -1,167
  -1,228
  -1,292
  -1,360
  -1,430
Cash from investing activities, $m
  -1,125
  -1,181
  -1,234
  -1,290
  -1,349
  -1,411
  -1,476
  -1,545
  -1,616
  -1,692
  -1,772
  -1,856
  -1,944
  -2,037
  -2,134
  -2,238
  -2,346
  -2,459
  -2,578
  -2,704
  -2,836
  -2,975
  -3,122
  -3,275
  -3,436
  -3,606
  -3,783
  -3,970
  -4,167
  -4,373
Free cash flow, $m
  1,678
  1,681
  1,694
  1,712
  1,735
  1,762
  1,794
  1,831
  1,871
  1,917
  1,785
  1,838
  1,897
  1,959
  2,027
  2,099
  2,176
  2,258
  2,345
  2,437
  2,535
  2,639
  2,748
  2,864
  2,987
  3,116
  3,252
  3,395
  3,547
  3,706
Issuance/(repayment) of debt, $m
  277
  334
  382
  429
  475
  522
  568
  615
  662
  711
  760
  811
  864
  918
  974
  1,033
  1,093
  1,156
  1,221
  1,290
  1,361
  1,435
  1,513
  1,594
  1,678
  1,767
  1,860
  1,957
  2,059
  2,166
Issuance/(repurchase) of shares, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash from financing (excl. dividends), $m  
  277
  334
  382
  429
  475
  522
  568
  615
  662
  711
  760
  811
  864
  918
  974
  1,033
  1,093
  1,156
  1,221
  1,290
  1,361
  1,435
  1,513
  1,594
  1,678
  1,767
  1,860
  1,957
  2,059
  2,166
Total cash flow (excl. dividends), $m
  1,955
  2,016
  2,076
  2,141
  2,210
  2,284
  2,362
  2,445
  2,534
  2,627
  2,545
  2,650
  2,761
  2,878
  3,001
  3,131
  3,269
  3,414
  3,566
  3,727
  3,896
  4,074
  4,261
  4,458
  4,665
  4,883
  5,112
  5,353
  5,606
  5,872
Retained Cash Flow (-), $m
  -103
  -110
  -126
  -141
  -157
  -172
  -187
  -203
  -218
  -234
  -251
  -268
  -285
  -303
  -321
  -341
  -360
  -381
  -403
  -425
  -449
  -473
  -499
  -526
  -554
  -583
  -613
  -645
  -679
  -714
Prev. year cash balance distribution, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
  33
  33
  34
  35
  36
  37
  38
  39
  41
  42
  44
  46
  48
  50
  52
  54
  56
  59
  61
  64
  67
  70
  74
  77
  81
  85
  89
  93
  97
  102
Cash available for distribution, $m
  1,851
  1,905
  1,950
  2,000
  2,053
  2,112
  2,175
  2,243
  2,315
  2,393
  2,294
  2,382
  2,476
  2,575
  2,680
  2,791
  2,908
  3,032
  3,163
  3,301
  3,447
  3,600
  3,762
  3,932
  4,111
  4,300
  4,499
  4,707
  4,927
  5,158
Discount rate, %
  8.60
  9.03
  9.48
  9.96
  10.45
  10.98
  11.52
  12.10
  12.71
  13.34
  14.01
  14.71
  15.44
  16.22
  17.03
  17.88
  18.77
  19.71
  20.70
  21.73
  22.82
  23.96
  25.16
  26.42
  27.74
  29.12
  30.58
  32.11
  33.71
  35.40
PV of cash for distribution, $m
  1,705
  1,603
  1,486
  1,368
  1,249
  1,131
  1,014
  899
  789
  684
  542
  459
  383
  314
  253
  201
  156
  119
  89
  65
  46
  32
  22
  14
  9
  6
  3
  2
  1
  1
Current shareholders' claim on cash, %
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0

DaVita Inc., formerly DaVita HealthCare Partners Inc., operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support. Its DMG division is a patient- and physician-focused integrated healthcare delivery and management company that provides medical services to members through capitation contracts. Its segments include U.S. dialysis and related lab services, DMG, and Other-Ancillary services and strategic initiatives. Its U.S. dialysis and related lab services line of business provide kidney dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease (ESRD). As of December 31, 2016, it had operated or provided administrative services to 154 outpatient dialysis centers.

FINANCIAL RATIOS  of  DaVita (DVA)

Valuation Ratios
P/E Ratio 15.5
Price to Sales 0.9
Price to Book 2.9
Price to Tangible Book
Price to Cash Flow 6.9
Price to Free Cash Flow 12
Growth Rates
Sales Growth Rate 7%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate 17.1%
Cap. Spend. - 3 Yr. Gr. Rate 6.1%
Financial Strength
Quick Ratio 7
Current Ratio 0
LT Debt to Equity 192.5%
Total Debt to Equity 196%
Interest Coverage 5
Management Effectiveness
Return On Assets 6.2%
Ret/ On Assets - 3 Yr. Avg. 4.9%
Return On Total Capital 6.3%
Ret/ On T. Cap. - 3 Yr. Avg. 4.6%
Return On Equity 18.5%
Return On Equity - 3 Yr. Avg. 13%
Asset Turnover 0.8
Profitability Ratios
Gross Margin 27.8%
Gross Margin - 3 Yr. Avg. 28.4%
EBITDA Margin 17.7%
EBITDA Margin - 3 Yr. Avg. 16.1%
Operating Margin 12.8%
Oper. Margin - 3 Yr. Avg. 11.8%
Pre-Tax Margin 10.1%
Pre-Tax Margin - 3 Yr. Avg. 8.5%
Net Profit Margin 6%
Net Profit Margin - 3 Yr. Avg. 4.5%
Effective Tax Rate 30.6%
Eff/ Tax Rate - 3 Yr. Avg. 35.2%
Payout Ratio 0%

DVA stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the DVA stock intrinsic value calculation we used $10877 million for the last fiscal year's total revenue generated by DaVita. The default revenue input number comes from 2017 income statement of DaVita. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our DVA stock valuation model: a) initial revenue growth rate of 2% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 8.6%, whose default value for DVA is calculated based on our internal credit rating of DaVita, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of DaVita.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of DVA stock the variable cost ratio is equal to 81.2%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $0 million in the base year in the intrinsic value calculation for DVA stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 5.4% for DaVita.

Corporate tax rate of 27% is the nominal tax rate for DaVita. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the DVA stock is equal to 0.3%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for DVA are equal to 86.5%.

Life of production assets of 10 years is the average useful life of capital assets used in DaVita operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for DVA is equal to -3%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $4690 million for DaVita - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 189 million for DaVita is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of DaVita at the current share price and the inputted number of shares is $13.2 billion.

RELATED COMPANIES Price Int.Val. Rating
ARA American Renal 15.88 10.49  sell
FMS Fresenius Medi 49.35 90.95  str.buy
THC Tenet Healthca 35.11 17.17  sell
SGRY Surgery Partne 14.15 23.80  buy

COMPANY NEWS

▶ DaVita Recognized for Veteran Outreach   [06:00AM  PR Newswire]
▶ DaVita Response to Legal Ruling   [Jun-27-18 11:50PM  PR Newswire]
▶ Is DaVita Inc (NYSE:DVA) Undervalued?   [Jun-21-18 12:55PM  Simply Wall St.]
▶ [$$] NEA Acquires Primary Medical Care Company Paladina Health   [Jun-06-18 08:30PM  The Wall Street Journal]
▶ These 10 Colorado companies landed on the 2018 Fortune 500   [May-21-18 02:33PM  American City Business Journals]
▶ DaVita HealthCare: 1Q Earnings Snapshot   [May-03-18 04:15PM  Associated Press]
▶ DaVita Inc. 1st Quarter 2018 Results   [04:01PM  PR Newswire]
▶ How Highmark and a provider are working to lower the cost of dialysis care   [Apr-24-18 02:20PM  American City Business Journals]
▶ DaVita Releases 10th Annual Community Care Report   [Apr-19-18 06:00AM  PR Newswire]
▶ [$$] UnitedHealth Increases Guidance for Year   [12:18AM  The Wall Street Journal]
▶ [$$] UnitedHealth Expects Help From Tax Changes   [Apr-17-18 04:12PM  The Wall Street Journal]
▶ Intel and DSW jump while Qualcomm and DaVita tumble   [Mar-13-18 04:32PM  Associated Press]
▶ DaVita eyes acquisitions, share buy-backs with cash windfall   [Feb-14-18 08:59AM  American City Business Journals]
▶ DaVita HealthCare tops 4Q profit forecasts   [04:27PM  Associated Press]
▶ DaVita Inc. 4th Quarter 2017 Results   [04:01PM  PR Newswire]
▶ DaVita Inc. to Host Earnings Call   [01:00PM  ACCESSWIRE]
▶ DaVita Earnings Preview   [11:27AM  Benzinga]
▶ The Evolution of My Research Process - Part I   [Feb-06-18 11:10AM  GuruFocus.com]
▶ UnitedHealth Group Inc Stock Requires Big Dose of Caution   [Jan-23-18 12:10PM  InvestorPlace]
▶ [$$] UnitedHealth Says Tax Overhaul To Boost 2018 Earnings   [12:25AM  The Wall Street Journal]
▶ [$$] UnitedHealth Says Tax Overhaul To Boost 2018 Earnings   [Jan-16-18 02:25PM  The Wall Street Journal]
▶ DaVita Celebrates 2017 Innovations and Achievements   [Jan-03-18 06:00AM  PR Newswire]
▶ ETFs with exposure to DaVita, Inc. : January 1, 2018   [Jan-01-18 11:33AM  Capital Cube]
▶ DaVita Celebrates Most Notable 2017 Awards   [Dec-26-17 11:30AM  PR Newswire]
▶ Man's Life Changed by Online Kidney Diet Resources   [Dec-21-17 10:46AM  PR Newswire]
▶ ETFs with exposure to DaVita, Inc. : December 19, 2017   [Dec-19-17 12:48PM  Capital Cube]
▶ DaVita settles False Claims Act allegations for $64 million   [Dec-15-17 11:34AM  American City Business Journals]
Follow us on:   twitter   twitter   twitter   twitter

ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2018. All rigths reserved.